IL-10 Is Critically Involved in Mycobacterial HSP70 Induced Suppression of Proteoglycan-Induced Arthritis
Open Access
- 14 January 2009
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 4 (1) , e4186
Abstract
The anti-inflammatory capacity of heat shock proteins (HSP) has been demonstrated in various animal models of inflammatory diseases and in patients. However, the mechanisms underlying this anti-inflammatory capacity are poorly understood. Therefore, the possible protective potential of HSP70 and its mechanisms were studied in proteoglycan (PG) induced arthritis (PGIA), a chronic and relapsing, T cell mediated murine model of arthritis. HSP70 immunization, 10 days prior to disease induction with PG, inhibited arthritis both clinically and histologically. In addition, it significantly reduced PG-specific IgG2a but not IgG1 antibody production. Furthermore, IFN-γ and IL-10 production upon in vitro restimulation with HSP70 was indicative of the induction of an HSP70-specific T cell response in HSP70 immunized mice. Remarkably, HSP70 treatment also modulated the PG-specific T cell response, as shown by the increased production of IL-10 and IFN-γ upon in vitro PG restimulation. Moreover, it increased IL-10 mRNA expression in CD4+CD25+ cells. HSP70 vaccination did not suppress arthritis in IL-10−/− mice, indicating the crucial role of IL-10 in the protective effect. In conclusion, a single mycobacterial HSP70 immunization can suppress inflammation and tissue damage in PGIA and results in an enhanced regulatory response as shown by the antigen-specific IL-10 production. Moreover, HSP70 induced protection is critically IL-10 dependent.Keywords
This publication has 40 references indexed in Scilit:
- The Foxp3+ regulatory T cell: a jack of all trades, master of regulationNature Immunology, 2008
- Induction of Oral Tolerance to HSP60 or an HSP60-Peptide Activates T Cell Regulation and Reduces AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- Stress, Heat Shock Proteins, and AutoimmunityAnnals of the New York Academy of Sciences, 2007
- Increased arthritis susceptibility in cartilage proteoglycan–specific T cell receptor–transgenic miceArthritis & Rheumatism, 2006
- Interleukin‐10‐secreting type 1 regulatory T cells in rodents and humansImmunological Reviews, 2006
- Inhibition of adjuvant‐induced arthritis by DNA vaccination with the 70‐kd or the 90‐kd human heat‐shock protein: Immune cross‐regulation with the 60‐kd heat‐shock proteinArthritis & Rheumatism, 2004
- Immune regulation in adjuvant‐induced arthritis: Possible implications for innovative therapeutic strategies in arthritisArthritis & Rheumatism, 2003
- β-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trialThe Lancet, 2001
- T cell responses to conserved bacterial heat-shock-protein epitopes induce resistance in experimental autoimmunitySeminars in Immunology, 1998
- Immunoregulatory role of interleukin 10 in rheumatoid arthritis.Journal of Experimental Medicine, 1994